Endocrine tumours of the gastrointestinal tract: Chemotherapy.

@article{Arnold2005EndocrineTO,
  title={Endocrine tumours of the gastrointestinal tract: Chemotherapy.},
  author={Rudolf Arnold and Anja Rinke and Ch Schmidt and LorenzC. Hofbauer},
  journal={Best practice & research. Clinical gastroenterology},
  year={2005},
  volume={19 4},
  pages={
          649-56
        }
}
Malignant neuroendocrine tumours are less sensitive to chemotherapy than other epithelial malignancies. If chemotherapy is considered, tumours of pancreatic origin have a higher sensitivity than tumours from the gastrointestinal tract ('carcinoids'). Chemotherapy with streptozocin combinations and with dacarbazine should be considered in patients with progressive malignant neuroendocrine tumours of the pancreas. A favourable response to chemotherapy can be expected in up to 60% of patients… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 28 CITATIONS

A single institution experience of streptozocin/fluorouracil combination chemotherapy: a case series

J. Naidoo, D. O’Toole, +3 authors K. O’Byrne
  • Irish journal of medical science
  • 2012

Similar Papers

Loading similar papers…